8-K - RHEP - Equibles

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of the

Securities

Exchange Act of 1934

Dateof report (Date of earliest event reported): July 29, 2025

RegionalHealth Properties, Inc.

(ExactName of Registrant as Specified in its Charter)

Georgia	001-33135	81-5166048
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

1050Crown Pointe Parkway

Suite720

Atlanta,Georgia 30338

(Addressof Principal Executive Offices, and Zip Code)

(678)869-5116

(Registrant’stelephone number, including area code)

Notapplicable.

(FormerName or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☒	Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title<br> of each class	Trading<br> Symbol(s)	Name<br> of each exchange on which registered
Common<br> Stock, no par value	RHEP^(1)^	N/A^(1)^
Series<br> A Redeemable Preferred Shares, no par value	RHEPA^(1)^	N/A^(1)^

(1) On June 11, 2025, NYSE American LLC (“NYSE American”) filed a Form 25 with the U.S. Securities and Exchange Commission to delist Regional Health Properties, Inc.’s (“Regional”) common stock, no par value (the “Common Stock”), and Regional’s Series A Redeemable Preferred Shares, no par value (the “Series A Preferred Stock”), from NYSE American. The Common Stock and the Series A Preferred Stock trade on the OTCQB under the symbols “RHEP” and “RHEPA,” respectively.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders

On July 29, 2025, Regional Health Properties, Inc. (“Regional”) convened a special meeting (the “Special Meeting”) of the holders of its common stock, no par value (the “Common Stock”). The Special Meeting was called to consider the proposals set forth in Regional’s joint proxy statement/prospectus filed with the Securities and Exchange Commission (the “SEC”) on June 25, 2025 (the “Joint Proxy Statement/Prospectus”) in connection with Regional’s proposed merger with SunLink Health Systems, Inc., a Georgia corporation (“SunLink”), whereby SunLink will merge with and into Regional (the “merger”), with Regional surviving the merger as the surviving corporation.

Below is a summary of the proposal that was submitted to the holders of Common Stock for approval at the Special Meeting and a tabulation of the votes with respect to such proposal.

RegionalAdjournment Proposal

The holders of Common Stock approved the adjournment of the Special Meeting for the purpose of soliciting additional votes to approve the Regional Merger Proposal (as defined in the Joint Proxy Statement/Prospectus) and the Regional Share Issuance Proposal (as defined in the Joint Proxy Statement/Prospectus) (the “Adjournment Proposal”). The Special Meeting will be adjourned to, and reconvene at, 1050 Crown Pointe Parkway, Atlanta, Georgia 30338, on Monday, August 4, 2025 at 10:00 a.m., Eastern Time. The voting results were as follows:

For	Against	Abstentions	Broker Non-Votes
1,043,581	298,162	13,382	—

Item 8.01 Other Events

On July 29, 2025, Regional convened the Special Meeting. Regional announced, during the Special Meeting and prior to adjournment of the Special Meeting, that the Special Meeting will be reconvened on Monday, August 4, 2025 at 10:00 a.m., Eastern Time, at 1050 Crown Pointe Parkway, Atlanta, Georgia 30338. The record date for determination of the holders of Common Stock entitled to notice of, and to vote at, the reconvened Special Meeting remains the close of business on June 20, 2025. Regional adjourned the Special Meeting pursuant to the Adjournment Proposal.

Any proxies previously submitted by the holders of Common Stock with respect to the Special Meeting convened and adjourned on July 29, 2025 will continue to be counted. Such holders need not submit a new proxy in order for their votes to be counted. The holders of Common Stock may revoke their proxies as set forth in the Joint Proxy Statement/Prospectus.

** *

| 2 |

| --- |

NO

OFFER OR SOLICITATION

Communications in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any proxy vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities Act”).

ADDITIONAL

INFORMATION

The proposed merger will be submitted to both the Regional and SunLink shareholders for their consideration. In connection with the proposed merger, Regional filed a Registration Statement on Form S-4 (File No. 333-286975) (the “Registration Statement”) with SEC that includes the Joint Proxy Statement/Prospectus for Regional and SunLink, which was sent to Common Stock shareholders of Regional and common stock shareholders of SunLink on or about June 30, 2025.

INVESTORS

ARE URGED TO READ THE REGISTRATION STATEMENT AND THE CORRESPONDING JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED MERGER, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, TOGETHER WITH ALL AMENDMENTS AND SUPPLEMENTS TO THOSE DOCUMENTS, AS THEY WILL CONTAIN IMPORTANT INFORMATION.

IN

ADDITION, INVESTORS ARE URGED TO READ THE TENDER OFFER STATEMENT ON SCHEDULE TO FILED WITH THE SEC ON JULY 18, 2025 REGARDING A PROPOSED TENDER OFFER, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, TOGETHER WITH ALL AMENDMENTS AND SUPPLEMENTS TO THOSE DOCUMENTS, AS THEY WILL CONTAIN IMPORTANT INFORMATION.

You are able to obtain a copy of the joint proxy statement/prospectus, as well as other filings containing information about Regional and SunLink, without charge, at the SEC’s website (http://www.sec.gov) or by accessing Regional’s website (http://www.regionalhealthproperties.com) under the tab “Investor Relations” or by accessing SunLink’s website (http://www.sunlinkhealth.com) under the tab “Investors.” Copies of the Joint Proxy Statement/Prospectus can also be obtained, without charge, by directing a request to Investor Relations, Regional Health Properties, Inc., 1050 Crown Pointe Parkway, Suite 720, Atlanta, Georgia, 30338, telephone 678-869-5116 or to Investor Relations, SunLink Health Systems, Inc., 900 Circle 75 Parkway, Suite 690, Atlanta, Georgia, 30339, telephone 770-933-7004.

Regional and SunLink and certain of their directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of Regional and SunLink in connection with the proposed merger. Information about the directors and executive officers of Regional is set forth in Part III of Regional’s Annual Report on Form 10-K for the year ended December 31, 2024 (the “Regional Annual Report”), which information may be updated by Regional from time to time in subsequent filings with the SEC. Information about the directors and executive officers of SunLink is set forth in Part III of SunLink’s Amendment No. 1 to Annual Report on Form 10-K/A for the fiscal year ended June 30, 2024, which information may be updated by SunLink from time to time in subsequent filings with the SEC. Additional information about the interests of those participants and other persons who may be deemed participants in the transaction may also be obtained by reading the Joint Proxy Statement/Prospectus relating to the proposed merger. Free copies of this document may be obtained as described above.

CautionaryNote Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Such forward-looking statements can often, but not always, be identified by the use of words like “believe”, “continue”, “pattern”, “estimate”, “project”, “intend”, “anticipate”, “expect” and similar expressions or future or conditional verbs such as “will”, “would”, “should”, “could”, “might”, “can”, “may”, or similar expressions. These forward-looking statements include, but are not limited to, statements relating to the reconvened Special Meeting.

| 3 |

| --- |

These forward-looking statements are subject to significant risks, assumptions and uncertainties that may cause results to differ materially from those set forth in forward-looking statements, including, among other things:

●	the<br> risk that the businesses of Regional and SunLink will not be integrated successfully or such<br> integration may be more difficult, time-consuming or costly than expected;
●	expected<br> revenue synergies and cost savings from the merger may not be fully realized or realized<br> within the expected timeframe;
●	revenues<br> following the merger may be lower than expected;
●	customer,<br> vendor and employee relationships and business operations may be disrupted by the merger;
●	the<br> ability to obtain required regulatory approvals or the approvals of Regional’s or SunLink’s<br> shareholders, and the ability to complete the merger on the expected timeframe;
●	the<br> costs and effects of litigation and the possible unexpected or adverse outcomes of such litigation;
●	the<br> ability of Regional and SunLink to meet the initial or continued listing requirements or<br> rules of the NYSE American LLC or the OTCQB, as applicable, and to maintain the listing or<br> trading, as applicable, of securities thereon;
●	possible<br> changes in economic and business conditions;
●	the<br> impacts of epidemics, pandemics or other infectious disease outbreaks;
●	the<br> existence or exacerbation of general geopolitical instability and uncertainty;
●	possible<br> changes in monetary and fiscal policies, and laws and regulations;
●	competitive<br> factors in the healthcare industry;
●	Regional’s<br> dependence on the operating success of its operators;
●	the<br> amount of, and Regional’s ability to service, its indebtedness;
●	covenants<br> in Regional’s debt agreements that may restrict its ability to make investments, incur<br> additional indebtedness and refinance indebtedness on favorable terms;
●	the<br> effect of increasing healthcare regulation and enforcement on Regional’s operators<br> and the dependence of Regional’s operators on reimbursement from governmental and other<br> third-party payors;
●	the<br> relatively illiquid nature of real estate investments;
●	the<br> impact of litigation and rising insurance costs on the business of Regional’s operators;
●	the<br> effect of Regional’s operators declaring bankruptcy, becoming insolvent or failing<br> to pay rent as due;
●	the<br> ability of any of Regional’s operators in bankruptcy to reject unexpired lease obligations<br> and to impede its ability to collect unpaid rent or interest during the pendency of a bankruptcy<br> proceeding and retain security deposits for the debtor’s obligations;
●	Regional’s<br> ability to find replacement operators and the impact of unforeseen costs in acquiring new<br> properties; and
●	other<br> risks and factors identified in (i) Regional’s cautionary language included under the<br> headings “Statement Regarding Forward-Looking Statements” and “Risk Factors”<br> in the Regional Annual Report, and other documents subsequently filed by Regional with the<br> SEC and (ii) SunLink’s cautionary language included under the headings “Forward-Looking<br> Statements” and “Risk Factors” in SunLink’s Annual Report on Form<br> 10-K for the year ended June 30, 2024, and other documents subsequently filed by SunLink<br> with the SEC.

Neither Regional nor SunLink undertake any obligation to update any forward-looking statement, whether written or oral, relating to the matters discussed in this Current Report on Form 8-K. In addition, Regional’s and SunLink’s past results of operations do not necessarily indicate either of their anticipated future results, whether the merger is effectuated or not.

| 4 |

| --- |

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	REGIONAL HEALTH PROPERTIES, INC.
Date:<br> July 30, 2025	/s/ Brent Morrison
	Brent<br> Morrison
	Chief<br> Executive Officer and President

| 5 |

| --- |